Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ABY 029

Next Previous
Drug Profile

ABY 029

Alternative Names: ABY-029 trifluoroacetate salt; fluorescently-labeled Anti-EGFR affibody molecule; IRDye 800CW maleimide-labeled affibody peptide

Latest Information Update: 31 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Affibody; Dartmouth College; LI-COR Biosciences
  • Developer Dartmouth College
  • Class Imaging agents; Peptide diagnostics
  • Mechanism of Action Diagnostic imaging enhancers; Epidermal growth factor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Glioma

Most Recent Events

  • 28 Jan 2020 No recent reports of development identified for phase-0 development in Glioma(Diagnosis) in USA (IV, Injection)
  • 20 Sep 2017 Dartmouth-Hitchcock Medical Center plans a phase I trial for Head and neck cancer in USA (NCT03282461)
  • 23 May 2017 Dartmouth College plans a phase 0 trial for Soft-tissue Sarcoma (Diagnosis) in USA (NCT03154411)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top